...
首页> 外文期刊>European review for medical and pharmacological sciences. >Preliminary proteomic analysis of radiation response markers in rectal cancer patients
【24h】

Preliminary proteomic analysis of radiation response markers in rectal cancer patients

机译:直肠癌患者辐射响应标志物的初步蛋白质组学分析

获取原文
           

摘要

OBJECTIVE: To provide biomarkers related to the radiation response of patients to avoid unnecessary side effects on those who were not sensitive to radiotherapy. PATIENTS AND METHODS: In the present study, we compared the different four proteins (PDIA3, Vimentin, Galectin3, Dhe3) patterns in rectal tumor tissue before and after radiation therapy by using 2-D PAGE, mass spectrometry, and bioinformatics analysis. RESULTS: The protein level of Galectin3 and PDIA3 were downregulated in rectal cancer patients before and after radiotherapy (1.42 folds); while Dhe3 protein and Vimentin were upregulated (1-2 folds), and we also revealed Vimentin as its role in the negative regulation of the well-known transcription factor ATF4. CONCLUSIONS: Our study showed that four candidate proteins, including PIDA3, Galectin3, Dhe3, and Vimentin, might be the potential biomarkers in the identification of radiation response in rectal cancer.
机译:目的:提供与患者的辐射响应相关的生物标志物,以避免对对放射治疗不敏感的人的不必要的副作用。患者和方法:在本研究中,通过使用2-D页,质谱和生物信息学分析,将不同的四种蛋白(PDIA3,Vimentin,Galectin3,DHE3)模式与直肠肿瘤组织进行比较。结果:在放疗前后直肠癌患者的Galectin3和Pdia3的蛋白质水平(1.42倍);虽然DHE3蛋白质和平节蛋白被上调(1-2倍),我们还揭示了在众所周知的转录因子ATF4的负调节中的作用。结论:我们的研究表明,四种候选蛋白质,包括PIDA3,Galectin3,DHE3和Vimentin,可能是潜在的生物标志物在鉴定直肠癌中的辐射反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号